BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 9794902)

  • 1. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D
    Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
    Palynyczko Z; Milewski B
    Mater Med Pol; 1975; 7(4):327-33. PubMed ID: 175222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [LP-X in newborns: increased incidence of positive tests without cholestasis (author's transl)].
    Witt I; Ober M
    J Clin Chem Clin Biochem; 1976 Apr; 14(4):197-202. PubMed ID: 5573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN; Alaupovic P
    Gastroenterology; 1976 Jul; 71(1):87-93. PubMed ID: 179911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC; Berthold S; Schlumpf E; Keller H; Riva G
    Schweiz Med Wochenschr; 1975 Jul; 105(27):863-72. PubMed ID: 2969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B; Palynyczko Z
    Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis.
    Simon JB; Poon RW
    Gastroenterology; 1978 Aug; 75(2):177-80. PubMed ID: 208914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.
    Walli AK; Seidel D
    J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic importance of low-density lipoprotein (LP-X) for the diagnosis of cholestasis].
    Michel B; Ritter U
    Z Gastroenterol; 1976 Sep; 14(5):556-64. PubMed ID: 184610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-X (LP-X) in liver disease.
    Ritland S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Gastroenterol; 1973; 8(2):155-60. PubMed ID: 4697077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipoprotein X (LP-X) in the differential diagnosis of cholestasis in children, with special reference to biliary atresia].
    Duchnowska A; Wach K; Poradowska W
    Probl Med Wieku Rozwoj; 1979; 8():84-91. PubMed ID: 263531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dyslipidemia in cholestasis].
    Bartellini A; Melazzini F; Oliveras R
    Acta Gastroenterol Latinoam; 1981; 11(2):291-9. PubMed ID: 7336851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-X and diagnosis of cholestasis: comparison with other biochemical parameters and liver biopsy.
    Fellin R; Manzato E; Zotti S; Baggio G; Briani G; Rugge M
    Clin Chim Acta; 1978 Apr; 85(1):41-7. PubMed ID: 25728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of lipoprotein X in the diagnosis of obstructive jaundice: comparison with other biochemical tests (author's transl)].
    Mayr K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2193-7. PubMed ID: 240665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic value of serochemical cholestasis parameters in liver cirrhosis].
    Rink C; Haerting J; Nilius R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():67-70. PubMed ID: 7483719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.